Interleukin-12

International Archives of Allergy and Immunology

Volumn 108, Issue 2, 1995, Pages 103-112

  Germann, Tieno ^a   Rüde, Erwin ^a  

^a Institute for Immunology ^*  (Germany)

Author keywords

Adjuvants; Autoimmunity; Cytokines; Infectious diseases; Receptor antagonists; Thi Th2

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 12;

ANTIGEN PRESENTING CELL; ANTIVIRAL ACTIVITY; AUTOIMMUNITY; B LYMPHOCYTE; BACTERIAL IMMUNITY; CELL ADHESION; CYTOTOXIC T LYMPHOCYTE; HELPER CELL; HEMATOPOIESIS; LYMPHOKINE ACTIVATED KILLER CELL; MACROPHAGE; MOLECULAR CLONING; MONOCYTE; NATURAL KILLER CELL; PARASITE IMMUNITY; PHAGOCYTE; PRIORITY JOURNAL; PROTEIN PURIFICATION; REVIEW; TUMOR IMMUNITY;

ANIMAL; ANTIBODY FORMATION; AUTOIMMUNE DISEASES; CELL DIFFERENTIATION; COMMUNICABLE DISEASES; HEMATOPOIESIS; HUMAN; HYPERSENSITIVITY; INTERLEUKIN-12; KILLER CELLS, NATURAL; RECEPTORS, INTERLEUKIN; SHOCK, SEPTIC; SIGNAL TRANSDUCTION; T-LYMPHOCYTES;

EID: 0029153226     PISSN: 10182438     EISSN: 14230097     Source Type: Journal    
DOI: 10.1159/000237126     Document Type: Article

References (119)

1. Wolf SK, Sieburth D, Sypek J: Interleukin 12: A key modulator of immune function. Stem Celts 1994:12:154-168.
2. Brunda MJ: Interleukin-12. J Leukoc Biol 1994:55:280 288.
3. Trinchieri G: Interleukin-12: A cytokine produced by antigen-presenting cells with immunoregulatory functions m the generation of T-helper cells type I and cytotoxic lymphocytes. Blood 1994:84:4008-4027.
4. Gubler L, Chua AO, Schoenhaut DS, Dwyer CM, McComas W, Motyka R, Nahavi N, Wolitzky AG, Quinn PM, Familletti PC, et al: Coexpression of two distinct genes is required to generate secreted bioaclive cytotoxic lymphocyte maturation factor. Proc Natl Acad Sci USA 1991;88:4143-4147.
5. Wolf SF, Temple PA, Kobayashi M, Young D, Dicig M, Lowe L, Dzialo R, Fitz L, Ferenz C, Hewiek RM, et al: Cloning of cDN A lor natural killer cell stimulatory factor, a heterodimcric cytokine with multiple biologic effects on T and natural killer cells. J Immunol 1991; 146:3074-3081.
6. Schoenhaut DS, Chua AO, Wolitzky AG, Quinn PM, Dwyer CM, McComas W, Familletti PC, Gatclv MK, Gubler U: Cloning and expression of murine IL-12. J Immunol 1992; 148:3433-3440.
7. Merberg DM, Wolf SF, Clark SC: Sequence similarity between NKSF and the IL-6/G-CSF family. Immunol Today 1992:13:77-78.
8. Zou JJ, Schoenhaut DS, Carvajal DM, Warricr RR, Presky DH, Galely MK, Gubler U: Structure-function analysis of the p35 subunit of mouse interleukin 12. J Biol. Chem 1995;270: 5864-5871.
9. Mattner F, Fischer S, Guckes S, Jin S, Kaulen H, Scmitt E, Rude E, Germann T: The inlerleukin-12 subunit p4U specifically inhibits effects of the interleukin-12 hetcrodimer. Eui J Immunol 1993;23:2202-2208
10. Gillessen S, Carvajal D, Ling P, Podlaski FJ, Stremio DL, Famillem PC, Gubler U, Presky DH, Stem AS, Galely MK: Mouse interleukin-t2 p40 homodimer: A potent IL-12 antagonist. Eur J Immunol: 1995:25:200-206.
11. Ling P, Gately MK, Gubler U, Stem AS, Lin P, Hollfelder K, Su C, Pan RYC, Hakimi J: Human IL-12 p40 homodimcr b inds lo the IL-12 receptor but does not mediate biologic activity. J Immunol 1995;154:116-127.
12. Gearing DP, Cosman D: Homology of the p40 subunit of natural killer cell stimulatory factor (NKSF) with the extracellular domain of the interleukin -6 receptor. Cell 1991;66:9-10.
13. Taga T, Hibi M, Hirala Y, Yamasaki K, Yasukaqa K, Matsuda T, Hirano T, Kishimoto T: Interleukin-6 triggers the association of its receptor with a possible signal transducer, gp 130. Cell 1989:58:573-581.
14. Ghua AO, Chizzonite R, Desai BB, Truin TP, Nunes P, Minetti LJ, Warner RR, Presky DH, Levine JF, Grately MK, Gubler U: Expression cloning of a human IL-12 receptor component: A new member of the cytokine receptor super-familv with strong homology to gp 130. J Immunol 1994;153:128-136.
15. Gerosa F, Tommasi M, Benati C, Gandini G, Libonali M, Tridente G, Catra G, Trinehieri G: Differential effects of tyrosine kinase inhibition in CD69 antigen exprcsenn and Iytic activity induced by rlL-2, rlL-12, and rlFN-ulpha in human NK cells. Cell Immunol 1993:150:382-390.
16. Pignata C, Sanghera JS, Cosserte L, Pelech SL, Ritz J: Interleukin-12 induces tyrosine phosphorylation and activation of 44-kD mitogen-activated protein kinase in human T cells. Blood 1994:83:184-190.
17. Bacon CM, McVicar DW, Ortaldo JR, Rees RC, O'Shea JJ, Johnston JA: Interleukin 12 (IL-12) induces tyrosine phosphoiylation of JAK2 and TYK2 Differential use of jinus family tyrosine kinases by 1L-2 and IL-12. J F.xp Med 1995; 181:399-404.
18. Kobayashi M, Fitz L, Ryan M, Hewiek RM, Clark SC, Chan S, Loudon R, Sherman F, Perussia B, Trinehieri G: Identification and purification of natural killer cell stimulatory factor (NKSF). a cytokine with multiple biologic effects on human lymphocytes. J Lxp Med 1989; 170:827-845.
19. Stern AS, Podlaski FJ, Holmes JD, Pan YC, Quinn PM, Wolitzky AG, Familletti PC, Stremio DL, Truitt T, Chizzonite R, et al: Purification to homogeneity and partial characterization of cylo:oxic lymphocyte maturation factor from human B-lymphobtastoid cells. Proc Natl Acad Sci USA 1990;87:6808-6812.
20. D'Andrea A, Rengaraju M, Valiante NM, Chehimi J, Kubin M, Aste M, Chan SH, Kobayashi M, Young D, Nickbarg E, et al: Production of natural killer cell stimulatory factor (interleukin 12) by peripheral blood mononuclear cells. J Exa Med 1992:176:1387-1398.
21. Wysocka M, Kubin M, Veira LQ, Ozmen L, Garotta G, Scott P, Trinehieri G: Interleukin 12 is required for interferon-gamma production and lethality in I ipopolysaccharide-induced shock in mice. Eur. J Immunol 1905:25:672-676
22. Yanagida T, Kato T, Igarashi O, Inoue T, Nariuchi H: Second signal activity of IL-12;n the proliferation and IL-2R expression of T helper cell-l clone. J Immunol 1994:152:4919-4928.
23. Kennedy MK, Picha KS, Shanebeck KD, Anderson DM, Grabstein KH: Interleukin-12 regulates the proliferation of Thl, but nol Th2 or ThO, clones. Eur J Immunol 1994:24:2271-2278.
24. Hsieh CS, Macatonia SE, Tripp CS, Wolf SF, O'Garra A, Murphy M: Development of Thl CD4-i-T cells through IL-12 produced by Listeria-induced macrophages (see comments). Science 1993;260:547-549.
25. Reiner SL, Zheng S, Wang ZE, Stowring L, Locksley RM: Leishmania promastigotes evade interleukin 12 (IL-12) induction by macrophages and stimulate a broad range of cytokines from CD4+ T cells during initiation of infection. J Exp Med 1994;179:447-456.
26. de Waal Malefyt R, Figdor CG, Huijbens R, Mohan Peterson S, Bennett B, Culpepper J, Dang W, Zurawski G, de Vries JE: Effects of IL-13 on plienotype. cytokine production, and cytotoxic function of human monocytes. Comparison with IL-4and modulation by IFN-gammaor IL-10. J Immunol 1993;151:6360-6381.
27. Tripp CS, Wolf SF, Unanue ER: Interleukin 12 and tumor necrosis factor alpha arc eoslimulators of interferon gamma production by natural killer cells in severe combined immunodeficiency mice with listeriosis and interleukin 10 is a physiologic antagonist. Proc Natl Acad Sci USA 1993;90:3725-3729.
28. Gazzinelli RT, Hieny S, Wynn TA, Wolf S, Sher A: Interleukin 12 is required for the T-lymphocyte- independent induction of interferon gamma by an intracellular parasite and induces resistance in T-cell-deficient hosts (see comments). Proc Natl Acad Sci USA 1993:90: 6115-6119.
29. Skeiky YAW, Guderian JA, Benson DR, Bacelar DR, Carvalho EM, Kubin M, Badaro R, Trinehieri G, Reed SG: A recombinant Icishmania antigen thai stimulates human peripheral blood mononuclear cells to express a Thl-type cyto- kine profile and to produce interleukin 12. J Exp Med 1995;181:1527-1537.
30. Germann T, Mattner F, Partenheimer A, Schmitl E, Reske Kunz AB, Fischer HG, Rude E: Different accessory function for Thl cells of bone marrow derived macrophages cultured in granulocyte macrophage colony stimulating factor of macrophage colony stimulating factor, Int Immunol 1992;4:755-764.
31. Shu U, Kiniwa M, Wu CY, Maliszewski C, Vezzio N, Hakimi J, Calely M, Delespesse G: Activated T cells induce interleukin-12 production by monocyte:: m t D40-C D40 ligand interaction. Eur J Immunol 1995;25:l125-1128.
32. Leung DYM, Glately M, Trumble A, Ferguson-Darnell B, Sehlievert PM, Picker LJ: Bacterial supcrantigens induce T cell expression of the skin-selective homing receptor, the cutaneous lymphocyte-associated antigen, via stimulation of interleukin 12 production. J Exp Med 1995; 181:747-753.
33. Scheicher C, Mehlig M, Dienes H-P, Reske K: Uptake of microparticle-adsorbed prclcin anti gen by bone marrow-derived dendritic cells results in up-regulation of interleukin-1 alpha and interleukin-12 p40/p35 and triggers prolonged, efficient antigen presentation. Eur J Immunol 1995;25:1566-1572.
34. Koch F, Ileufler C, Standi U, Topar G, Wysocka M, Trinehieri G, Enk A, Romani N, Schuler G: Interleukin-12 is produced by dendritic cells and mediates Th I development as well as IFN-gamma production by Th I cells. Submitted.
35. Cassatella MA, Meda L, Gasperini S, D'Andrea A, Ma X, Trinehieri G: Interleukin-12 production by human polymorphonuclear leukocytes Eur J Immunol 1995;25:1-5.
36. Muller G, Saloga J, Gennann T, Bellinghausen I, Mohamadzadeh M, Knop J, Enk AH: Identification and induction of human kcratinocyte-derived IL-12, J Clin Invest 1994:94:1799-1805.
37. Aragane Y, Riemann H, Bhardwaj RS, Schwarz A, Sawada Y, Yamada H, Luger TA, Kubin M, Trinehieri G, Schwarz T: IL-12 is expressed and released by human kernatinocytes and epideroid carcinoma cell lines. J Immunol 1994; 153:5366-5372.
38. Godfrey DL, Kennedy J, Gately MK, Hakimi J, Hubbard BR, Zlotnik A: IL-12 influences intralhymic T cell development. J Immunol 1994; 152:2729-2735.
39. D'Andrea A, Aste Amezaga M, Valiante NM. Ma X. Kubin M, Trinechieri G: Interleukin 10 (IL-10) inhibits human lymphocyte interferon gam ma-product ion by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells, J Exp Med 1993:178:1041-1048.
40. Fischer S, Jin S-C, Mattner F, Rüde E, Germann T; The production of IL 12 by macrophages activated with bacteria or Thl cells is downreg-Ukited by IL 10 (abstract C8). Immunobiology 1993:189 1-2:40-41.
41. Murphy EE, Terres G, Macatonia SE, Hsich CS, Maltson J, Lanier L, Wysocka M, Trinehieri G, Murphy K, O'Garra A; B7 and interleukin 12 cooperate for proliferation and interferon gamma production by mouse T helper clones lhal arc unresponsive to B7 costimulation. J Exp Med 1994.180:223-231.
42. Kubin M, Kamoun M, Trinehieri G: Interleukin 12 synergies with B7/CD28 interaction in inducing efficient proliferation and cytokine production of human T cells, J Exp Med 1994; 180: 211-222.
43. D'Andrea A, Ma X, Aste-Amezaga M, Paganin C, Trinehieri G: Stimulatory and inhibitory effects of interleukin (IL)-4and IL-13 on the product ion of cytokines by human peripheral blood mononuclear cells: Priming for IL-12 and tumor necrosis factor alpha production. J Exp Med 1995:181:537-546.
44. Tineke CT, Pouw Kraan M, Boeije ICM, Smcenk RJT, Wijdenes J, Aarden LA: Prosta-glandin-E2 is a potent inhibitor of human interleukin 12 production. J Exp Med 1995:181: 775-779.
45. Heinzel FP, Rerko RM, Ling P, Hakimi J, Schoenhaut DS: Interleukin-12 is produced in vivo during endotoxemia and stimulates synthesis of interferon-gamma. Infect Immun 1994:62:4244-4249.
46. Zhang M, Galely MK, Wang E, Gong J, Wolf SF, Lu S, Modlin RL, Barnes PF: Interleukin-12 at the site of disease in tuberculosis. J Clin Invest 1994;93:1733-1738.
47. Bene M, Jin SC, Germann T, Schafer MKH, Weihe E, Rude E, Fleischer B: Differential expression of mRN A encoding interleukin-12 p35 and p40 subunits in situ. Eur J Immunol 1994; 24:2435-2440.
48. Wu CY, Demeure C, Kiniwa M, Galely M, Delespesse G: IL-12 induces the production of IFN-gamma by neonalal human CD4 T cells. J Immunol 1993;151:1938-1949.
49. Schmitt E, Hoehn P, Huels C, Goedert S, Palm N, Rude E, Germann T; T helper type 1 development of naive CD4+ T cells requires the coordinate action of interleukin-12 and interferongamma and is inhibited by transforming growth factor-beta. Eur J Immunol 1994:24:793-798.
50. Hunter GA, Bemiudez L, Becmink H, Waege W, Remington JS. Transforming growth facto: beta inhibits interleukin-12 induced productio of interferon-gamma by natural killer cells:, role for transforming growth facior-beta in th regulation of T ccM-indepcndcnt resistance t Toxoplasma gondii. Eur J Immunol 1995:25: 994-1000.
51. Desai BB, Quinn PM, Wolitzky AG, Mongin PK, Chizzonite R, Galely MK: II.-12 recepto II. Distribution and regulation of receptor expression, J Immunol 1992:148:3125-3132.
52. Gately MK, Desai BB, Wolitzky AG, Quin PM, Duyer CM, Podlaski FJ, Familletti PC, Snigaglia F, Chizonnite R, Gubler L, et al: Regt lalion of human lymphocyte proliferation by heterodimeric cytokine. IL-12 (cytoloxic lyn phocyle maturation factor). J Immunol 1990 147:874-882.
53. Bertagnolli MM, Lin BY, Young D, Herrman SH: IL-12 augments antigen-dependent proliferation of activated T lymphocytes. J Immunt 1992;149:3778-3783.
54. Perussia B, Chan SH, D’Andrea A, Tsuji K, Santoli D, Pospisil M, Young D, Wolf SF, Trinchic C; Natural killer (NK.) cell stimulatory factor i IL-12 has differential effects on the proliferation of TRC-alpha beta-. TCR-gamma delta+ lymphocytes, and NK cells. J Immunol 1991 149:3495-3502.
55. Mehrotra PT, Wu D, Crim JA, Mostowski HS, Siegel JP: Effects of IL-12 on the generation i cytotoxic activity in human CD8+ T lymphi cytes. I Immunol 1993;151:2444-2452.
56. Chouaib S, Chehimi J. Bani L, Genetet N, Turs T, Gay F, Trinehieri G, Mami-Chouaib F: Inteleukin 12 induces the differentiation of majc histocompatibility complex class I-primed cytotoxic T-lymphocyte precursors into allospecific cytoloxic effectors. Proc Natl Acad S. USA 1994;91:12659-12663.
57. Naume B, Gately MK, Desai BB, Sundan A, Espevik T: Synergistic effect interleukin and interleukin 12 on NK cell proliferation. Cytokine 1993:5:38-46.
58. Quill H, Bhandoola A, Trinehieri G, Haluskt J, Peritt D: Induction of interleukin 12 responsiveness is impaired in anergic T lymphacyte J Exp Med 1994:179:1065-1070.
59. Robertson MJ, Soiffer RJ, Wolf SF, Mauley T, Donahue C, Young D, Herrmann SH, Ritz J: Response of human natural killer (NK) cells to N cell stimulatory factor (NKSF): Cytolytic actvity and proliferation of NK cellsare differentia regulated by NKSF. J Exp Med 1992:17 779-788.
60. Gately MK, Warrier RR, Honasoge S, Carvaj DM, Faherty DA, Connaughton SF, Andersc TD, Sarmiento U, Hubbard BR, Murphy M. Administration of recombinant IL-12 to norm mice enhances cytolytic lymphocyte activi and induces production of lFN-g in vivo. Int In munol 1994;6:157-67.
61. Chan SH, Perussia B, Gupta JW, Kobayashi M, Pospisil M, Young HA, Wolf SF, Young D, Clark SC, Trinehieri G: induction of interferon gamma production by natural killer cell stimulatory factor: Characterization of the responder cells and synergy with other inducers. J Exp Med 1991:173:869-879.
62. Germann T, Gately MK, Schoenhaut DS, Lohoff M, Mattner F, Fischer S, Jin SC, Schmitt E, Rüde E: IL-I2/TSF a cytokine with multiple effects on Thl. but not on Th2 cells. EurJ Immunol 1993:23:1762-1770.
63. Chan SH, Kobayashi M, Santoli D, Perussia B, Trinehieri G: Mechanisms or IFN-gamma induction by natural killer cell stimulatory factor (NKSF/IL-12). Role of transcription and mRNA stability in the synergistic interaction between NKSF and IL-2. J Immunol 1992:148: 92-98.
64. Naumc B, Galely M, Espevik T: A comparative study of IL-12 (cytotoxic lymphocyte maturation factor)-. IL-2-. and IL-7-induccd effects on immunomagnelically purified CD56+ NK cells. J Immunol 1992; 148:2429-2436.
65. Gatcly MK, Wolitzky AG, Quinn PM, Chiminite R: Regulation of human cytolytic lymphocyte responses by interleukin-12. Cell Immunol 1992;143:127-142.
66. Chehimi J, Starr SE, Frank I, Rengaraju M, Jackson SJ, Llancs C, Kobayashi M, Perussia B, Young D, Nickbarg F, et al: Natural killer (NK) cell stimulatory factor increases the cytotoxic activity of NK cells from both healthy donors and human immunodeficiency vims-infected patients. J Exp Med 1992;175:789-796.
67. Bloom ET, Horvalh JA: Cellular and molecular mechanisms of the IL-12-induced increase in allospecilic murine cytolytic T cell activity. Implications for the age-related decline in CTL. J Immunol 1994:152:4242-4254.
68. Cesano A, Visonneau S, Clare SC, Santoli D: Cellular and molecular mechanisms of activation of MFIC nonrcslrieted cytotoxic cells by IL-12. J Immunol 1993:151:2943-2957.
69. Jelinek DF, Braaten JK: Roleof IL-12 inhuman B lymphocyte proliferation and differentiation. Jlmmunol 1995:154:1606-1613.
70. DeKruyff RH, Fang Y, Wolf SF, Umetsu DT: IL-12 inhibits IL-4 synthesis in keyhole limpet hemocyanin-primed CD4+ Cells through an effect on antigen-presenting cells. J Immunol 1995;154:2578-2587.
71. Jacobsen SE, Veiby OP, Smeland EB: Cytotoxic lymphocyte maturation factor limcrleukin 121 is a synergistic growth factor for hematopoietic stem cells. J Exp Med 1993;178:413-418.
72. Hirayama F, Katayama N, Neben S, Donaldson D, Nickbarg EB, Clark SC, Ogawa M: Synergistic interaction between inlerleukin-12 and steel factor in suppon of proliferation of murine Ivmphohemalopoietic progenitors in culture. Blood 1994:83:92-98.
73. Bellone G, Trinehieri G: Dual stimulatory and inhibitory effect of NK cell stimulatory factor/ IL-12 on human hematopoiesis. J Immunol 1994:153:930-937.
74. Pfeffer K, Matsuyama T, Kundig TM, Wakeham A, Kishihara K, Shahinian A, Wiegmann K, Ohashi PS, Kronke M, Mak TW: Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet Succumb to L. monocytogenes infection. Cell 1993: 73:457-567.
75. Rothe J, Lesslaucr W, Lotscher H, Lang Y, Koebel P, Konlgen F, Allhage A, Zinkemagel R, Sleinmetz M, Bluethmami H: Mice lacking the tumour necrosis Tact or receptor 1 are resistant to TNF-mediated toxicity but highly susceptible to infection by Listeria monocytogenes, Nature 1993:364:798-802.
76. Tripp CS, Gately MK, Hakimi J, Ling P, Unanue ER: Neutralization of IL-12 decreases resistance to Listeria in SCID and C.B-17 mice. Reversal by IFN-gamma. J Immunol 1994:152; 1883-1887.
77. Gazzinelli RT, Wysocka M, Hayashi S, Denkers BY, Hieny S, Caspar P, Trinehieri G, Sher A: Parasite-induced IL-12 stimulates early 1FN-ganuna synthesis and resistance during acute infection with Toxoplasma gondii. I Immunol 1994:153:2533-2543.
78. Sypek JP, Chung CL, Mayor SE, Subramanyam JM, Goldman SJ, Sieburlh DS, Wolf SF, Sehaub RG: Resolution of cutaneous lyshmaniasis: Interleukin 12 initiates a protective T helper type I immune response. J Exp Med 1993:177: 1797-1802.
79. Bohn E, Autenrielh IB: Interleukin-12 promotes resistance of mice against entcro pathogenic Yersinia by triggering IFN-gamma production in NK cells and CD4+ T cells. Submitted.
80. Romani L, Mencacci A, Tonetti L, Spaccapclo R, Cenci E, Puccetti P, Wolf SF, Bistoni F: IL-12 is both required and prognostic in vivo for T helper type I differentiation in murine candidiasis. J Immunol 1994;152:5167-5175.
81. Hcinzel FP, Schoenhaut DS, Rerko RM, Rosser LE, Gately MK: Recombinant interleukin 12 curses mice infected with Leisknumia major. J Exp Med 1993; 177:1505-1509.
82. Wang Z, Zheng S, Cony DB, Dalton DK, Seder RA, Reiner SL, Loeksley RM: Interferon-gamin a-independent effects of interleukin-12 administered during acute or established infection with Lsishmarda major. Proc Natl Acad Sci. USA 1994:91:12932-12936.
83. Wynn TA, Eltoum I, Oswald IP, Cheever AW, Sher A: Endogenous interleukin 12 (IL-12) reglates granuloma formation induced by eggs of Schistosoma moitsoni and exogenous IL-12 both inhibit and prophyiaeticallv immunizes against egg pathology. J Exp Med I994;179; 1551-1561.
84. Oswald IP, Caspar P, Jankovic D, Wynn TA, Pearce FJ, Slier A: IL-12 inhibits Th2 cytokine responses induced by eggs of Schistosoma minisoni. J Immunol 1994:153:1707-1713.
85. Khan IA, Malsuura T, Kasper H: Interleukin-12 enhances murine survival against acute toxoplasmosis. Infect Immun 1994:62:1639-1642.
86. Afonso LCC, Scharton TM, Vieira LQ, Wysocka M, Trinehieri G, Scott P: The adjuvant effect of interleukin-12 in a vaccine against Leishmania major. Science 1994;263:235-238.
87. Sieling PA, Wang XH, Gately MK, Oliveros JL, McHugh T, Barnes PF, Wolf SF, Golkar L, Yamamura M, Yogi Y, et al: IL-12 regulates T helper type I cytokine responses in human infectious disease. J Immunol 1994:153:3639-3647.
88. Ozmen L, Pericin M, Hakimi J, Chizzonite RA, Wysocka M, Trinehieri G, Gatelv M, Garotta G: Interleukin 12. interferon gamma, and tumor necrosis factor alpha are the key cytokines of the generalized Shwart/man reaction. J Exp Med 1994;180:907-915.
89. Orange JS, Wolf SF, Biron CA: Effects of IL-12 on the response and susceptibility to experimental viral infections. J Immunol 1994; 152:1253-1264.
90. Orange JS, Salazar-Mather TP, Opal SM, Spencer RL, Miller AH, McEwen BS, Biron CA: Mechanism of interleukin 12-mediated toxicities during experimental viral infections: Role of tumor necrosis factor and glucocorticoids. J Exp Med 1995:181:901-914.
91. Gazanetli RT, Gicse NA, Morse HC III: Invito treatment with interleukin-12 protects mice from immune abnormalities observed during murine acquired immunodeficiency syndrome (MAIDS). J Exp Med 1994;180:2199-2208.
92. Chehimi J, Starr SE, Frank I, D’Andrea A, Ma X, MacGregor RR, Sennelier J, Trinehieri G: Impaired interleukin 12 production in human immunodeficiency vims-inleeted patients. J Exp Med 1994; 179:1361-1366.
93. Clerici M, Lucey DR, Berzofskyy A, Pinto LA, Wynn TA, Blatt SP, Dolan MJ, Hendrix CW, Wolf SF, Shearer GM: Restoration of HI Vspe-cific cell-mediated immune responses by interleukin-l2invitro. Science 1993;262:1721-1724.
94. Brunda MJ, Luistro L, Warrier RR, Wright RB, Hubbard BR, Murphy M, Wolf SF, Gately MK: Antitumor and ami metastatic activity of interleukin 12 against murine tumors. J Exp Med 1993;17B:1223-1230.
95. Nastala CL, Edinglon HD, McKmney TG, Taharn H, Nalesnik MA, Brunda MJ, Gately MK, Wolf SF, Schreiber RD, Storkus WJ, et al: Recombinant IL-12 administration induces tumor regreszbn in association With IFN-gamma production. J Immunol 1994; 153:1697-1706.
96. Noguchi Y, Richards EC, Chen Y, Old LJ: Influence or interleukin 12 onp53 peptide vaccination against established methasarcoma. Proc Natl Acad Sci USA 1995;92:2219-2223.
97. Martinotli A, Stoppacciaro A, Vagliani M, Metani C, Spreaiico F, Wysocka M, Parmiani G, Trkhieri G, Colombo MP: CD4 T cells inhibit in vivo the CD8-mediated immune response against murine colon carcinoma cells transduced with interleukin-12 genes. EurJ Immunol 1995;25:137-146.
98. Liblau RS, Singer SM, McDevitt HO: Thl and Th2 CD4+ T cells in the pathogenesis of organ-specific autoimmune diseases. Immunol Today 1995;16:34-38.
99. Leonard JP, Waldburger KF, Goldman SJ: Prevention of experimental autoimmune encephalomyelitis by antibodies against interleiikin 12. J Exp Med 1995;181:381-386.
100. Trembleau S, Penna G, Btisi E, Mortara A, Gatcly MK, Adorini L: Interleukin 12 administration induce T helper type I cells and accelerates autoimmune diabetes in NOD mice J Exp Med 1995:181:817-821.
101. Germann T, Szcliga J, Hess H, Storkel S, Podlaski FJ, Gately MK, Schmitt E, Rude E: Administration of interleukin-12 in combination with type II collagen induces severe arthritis in DBA. I mice, Proc Natl Acad Sci USA 1995; 92:4823-4827.
102. Ogata LC, Reilly C, Marconi LAM, Lo D: An-ti-IL-12 antibody can prevent autoimmune diabetes in an adoptive transfer murine model (abstract C2 463). J Cell Biochem 1995 (supp1 21A):150.
103. Neurath MF, Fuss I, Kelsall BL, Stüber E, Strober W: Antibodies lo IL-12 abrogate established granulomatous ciditis in mice. J exp Med, in press.
104. Seder RA, Gazzinelli R, Sher A, Paul WE: Interleukin 12 acts directly on CD4+ T cells to enhance priming for interferon gamma production and diminishes interleukin 4 inhibition of such priming. Proc Natl Acad Sci USA 1993;90:10188-10191
105. Manetti R, Parrouchi P, Giudizi MG, Piccinni MP, Maggi E, Trinehieri G, Romagnani S: Natural killer cell stimulatory factor (interleukin 12 [IL-12]) induces T helper type I (Thl)-specific immune responses and inhibits the development of IL-4-producingTh cells. J Exp Med 1993;177:1199-1204.
106. Manetti R, Gerosa F, Giudizi MG, Biagiotli R, Parronohi P, Piccinni MP, Sampognaro S, Maggi E, Romagnani S, Trinehieri G, et al: Interleukin 12 induces stable priming for interferon gamma (IFN-gamma) production during differentiation of human T helper (Th) cells and transient IFN-gamma production in established Th2 cell clones. J Exp Med 1994; 179:1273-1283.
107. Finkelman FD, Madden KB, Cheever AW, Katona IM, Morris SC, Gately MK, Hubbard BR, Gause WC, Urban JFJ: Effects of interleukin 12 on immune responses and host protection in mice infected with intestinal nematode parasites (see comments). J Exp Med 1994:179: 1563-1572.
108. McKnight AJ, Zimmcr GJ, Fogelman I, Wolf SF, Abbas AK: Effects of IL-12 on helper I cell-dependent immune responses in vivo. J Immunol 1994:152:2172-2179.
109. Germann T, Bongartz M, Dlugonska H, Hess H, Schmitt F, Kolbe L, Kolsch E, Podlaski FJ, Gately MK, Rude E: IL-12 profoundly upregulates the synthesis of antigen-specific, complement-fixing lgG2a, lgG2b and lgG3 antibody subclasses in vivo. Eur J Immunol 1995:25 823-829.
110. Scott P: IL-12: Initiation cytokine for cell-mediated immunity (comment). Science 1993; 260:496-497.
111. Kiniwa M, Gately M, Gubler U, Chizzonite R, Fargeas C, Delespesse G: Recombinant interleukin-12 suppresses the synthesis of immunoglobulin E by interleukin-4 stimulated human lymphocytes. J Clin Invest 1992:90:262-266.
112. Morris SC, Madden KB, Adamovicz JJ, Gause WC, Hubbard BR, Gately MK, Finkelman FD: Effects of IL-12 on in vivo cytokine gene expression and Ig isotype selection. J Immunol 1994:152:1047-1056.
113. Germann T, Guckes S, Bongarlz M, Schmitt E, Kolbe L, Kotsch E, Podlaski FJ, Gately MK, Rude E: Administration of interleukin-12 fails to permanently suppress and can even enhance the synthesis of antigen-specific lgE in vivo. Im Immunol, in press.
114. Schmitt E, Hoehn P, Germann T, Rude E: Differential effects of interluken-12 on the development of naive mouse CD4+ T cells. Eur J Immunol 1994;24:343-347.
115. Wu CY, Demeure CE, Gately M, Podlaski F, Yssel H, Kiniwa M, Delespesse G: In vitro maturation of human neonatal CD4 T lymphocytes. I. Induction of IL-4-producing cells alter tang-term culture in the presence of IL-4 plus either 11.-2 or IL-12. J Immunol 1994:152: 1141-1153.
116. Shu U, Demeure CE, Byun D, Podlaski FJ, Stem AS, Delespesse G: Interleukin-12 exerts a differential effect on the maturation of neonatal and adult human CD45RO- CD4+ T cells. J Clin Invest 1994;94:1352-1358.
117. Alonza M, Jack H-M, Fisher RI, Ellis TM: IL-12 activates IFN-gamma production through the preferential activation ofCD30+ T cells. J Immunol 1995;154:9-16.
118. Müller G, Saloga J, Germann T, Knop J, Schuler G, Enk AH; IL-12 as mediator and adjuvant for the induction of contact sensitivity in vivo Submitted.
119. Riemann H, Grabbe S, Schwarz A, Aragane Y, Luger TA, Wysocka M, Kubin M, Trinehieri G, Schwarz T, Boltzmann L: In vivo application of an interleukin 12 antibody induces hapten specific tolerance (abstract 98). J Invest Dermatol 1995:104:571.